Quest Diagnostics Gross Profit Growth & History (DGX)
Quest Diagnostics's gross profit was $3.67B for fiscal 2025.
View full Quest Diagnostics company overviewQuest Diagnostics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.67B | $421.0M | +12.98% |
| 2024 | 2024-12-31 | $3.24B | $191.0M | +6.26% |
| 2023 | 2023-12-31 | $3.05B | −$380.0M | −11.07% |
| 2022 | 2022-12-31 | $3.43B | −$776.0M | −18.44% |
| 2021 | 2021-12-31 | $4.21B | $576.0M | +15.85% |
| 2020 | 2020-12-31 | $3.63B | $944.0M | +35.11% |
| 2019 | 2019-12-31 | $2.69B | $84.0M | +3.22% |
| 2018 | 2018-12-31 | $2.60B | −$78.0M | −2.91% |
| 2017 | 2017-12-31 | $2.68B | −$216.0M | −7.45% |
| 2016 | 2016-12-31 | $2.90B | $63.0M | +2.22% |
| 2015 | 2015-12-31 | $2.84B | $38.0M | +1.36% |
| 2014 | 2014-12-31 | $2.80B | −$22.0M | −0.78% |
| 2013 | 2013-12-31 | $2.82B | −$198.0M | −6.56% |
| 2012 | 2012-12-31 | $3.02B | −$11.0M | −0.36% |
| 2011 | 2011-12-31 | $3.03B | −$22.7M | −0.74% |
| 2010 | 2010-12-31 | $3.05B | −$82.1M | −2.62% |
| 2009 | 2009-12-31 | $3.13B | $140.5M | +4.69% |
| 2008 | 2008-12-31 | $2.99B | $258.2M | +9.44% |
| 2007 | 2007-12-31 | $2.74B | — | — |
Quest Diagnostics quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.03B | $84.0M | +8.91% |
| Q1 2026 | 2026-03-31 | $942.0M | $79.0M | +9.15% |
| Q4 2025 | 2025-12-31 | $910.0M | $52.0M | +6.06% |
| Q3 2025 | 2025-09-30 | $949.0M | $138.0M | +17.02% |
| Q2 2025 | 2025-06-30 | $943.0M | $139.0M | +17.29% |
| Q1 2025 | 2025-03-31 | $863.0M | $92.0M | +11.93% |
| Q4 2024 | 2024-12-31 | $858.0M | $122.0M | +16.58% |
| Q3 2024 | 2024-09-30 | $811.0M | $57.0M | +7.56% |
| Q2 2024 | 2024-06-30 | $804.0M | $12.0M | +1.52% |
| Q1 2024 | 2024-03-31 | $771.0M | $0 | 0.00% |
| Q4 2023 | 2023-12-31 | $736.0M | −$22.0M | −2.90% |
| Q3 2023 | 2023-09-30 | $754.0M | −$114.0M | −13.13% |
| Q2 2023 | 2023-06-30 | $792.0M | −$50.0M | −5.94% |
| Q1 2023 | 2023-03-31 | $771.0M | −$194.0M | −20.10% |
| Q4 2022 | 2022-12-31 | $758.0M | −$268.0M | −26.12% |
| Q3 2022 | 2022-09-30 | $868.0M | −$236.0M | −21.38% |
| Q2 2022 | 2022-06-30 | $842.0M | −$143.0M | −14.52% |
| Q1 2022 | 2022-03-31 | $965.0M | −$129.0M | −11.79% |
| Q4 2021 | 2021-12-31 | $1.03B | −$243.0M | −19.15% |
| Q3 2021 | 2021-09-30 | $1.10B | −$102.0M | −8.46% |
| Q2 2021 | 2021-06-30 | $985.0M | $379.0M | +62.54% |
| Q1 2021 | 2021-03-31 | $1.09B | $542.0M | +98.19% |
| Q4 2020 | 2020-12-31 | $1.27B | $607.0M | +91.69% |
| Q3 2020 | 2020-09-30 | $1.21B | $514.0M | +74.28% |
| Q2 2020 | 2020-06-30 | $606.0M | −$82.0M | −11.92% |
| Q1 2020 | 2020-03-31 | $552.0M | −$95.0M | −14.68% |
| Q4 2019 | 2019-12-31 | $662.0M | $58.0M | +9.60% |
| Q3 2019 | 2019-09-30 | $692.0M | $25.0M | +3.75% |
| Q2 2019 | 2019-06-30 | $688.0M | $12.0M | +1.78% |
| Q1 2019 | 2019-03-31 | $647.0M | −$11.0M | −1.67% |
| Q4 2018 | 2018-12-31 | $604.0M | −$67.0M | −9.99% |
| Q3 2018 | 2018-09-30 | $667.0M | $1.0M | +0.15% |
| Q2 2018 | 2018-06-30 | $676.0M | −$18.0M | −2.59% |
| Q1 2018 | 2018-03-31 | $658.0M | $6.0M | +0.92% |
| Q4 2017 | 2017-12-31 | $671.0M | −$30.0M | −4.28% |
| Q3 2017 | 2017-09-30 | $666.0M | −$62.0M | −8.52% |
| Q2 2017 | 2017-06-30 | $694.0M | −$57.0M | −7.59% |
| Q1 2017 | 2017-03-31 | $652.0M | −$67.0M | −9.32% |
| Q4 2016 | 2016-12-31 | $701.0M | $2.0M | +0.29% |
| Q3 2016 | 2016-09-30 | $728.0M | $10.0M | +1.39% |
| Q2 2016 | 2016-06-30 | $751.0M | $8.0M | +1.08% |
| Q1 2016 | 2016-03-31 | $719.0M | $43.0M | +6.36% |
| Q4 2015 | 2015-12-31 | $699.0M | $0 | 0.00% |
| Q3 2015 | 2015-09-30 | $718.0M | −$8.0M | −1.10% |
| Q2 2015 | 2015-06-30 | $743.0M | $15.0M | +2.06% |
| Q1 2015 | 2015-03-31 | $676.0M | $31.0M | +4.81% |
| Q4 2014 | 2014-12-31 | $699.0M | −$6.0M | −0.85% |
| Q3 2014 | 2014-09-30 | $726.0M | $27.0M | +3.86% |
| Q2 2014 | 2014-06-30 | $728.0M | $7.0M | +0.97% |
| Q1 2014 | 2014-03-31 | $645.0M | −$50.0M | −7.19% |
| Q4 2013 | 2013-12-31 | $705.0M | $4.0M | +0.57% |
| Q3 2013 | 2013-09-30 | $699.0M | −$42.0M | −5.67% |
| Q2 2013 | 2013-06-30 | $721.0M | −$55.0M | −7.09% |
| Q1 2013 | 2013-03-31 | $695.0M | −$105.0M | −13.13% |
| Q4 2012 | 2012-12-31 | $701.0M | −$78.4M | −10.06% |
| Q3 2012 | 2012-09-30 | $741.0M | −$26.7M | −3.48% |
| Q2 2012 | 2012-06-30 | $776.0M | −$1.3M | −0.17% |
| Q1 2012 | 2012-03-31 | $800.0M | $95.4M | +13.55% |
| Q4 2011 | 2011-12-31 | $779.4M | $35.8M | +4.82% |
| Q3 2011 | 2011-09-30 | $767.7M | −$5.5M | −0.71% |
| Q2 2011 | 2011-06-30 | $777.3M | −$18.5M | −2.32% |
| Q1 2011 | 2011-03-31 | $704.6M | −$34.6M | −4.68% |
| Q4 2010 | 2010-12-31 | $743.6M | −$34.4M | −4.43% |
| Q3 2010 | 2010-09-30 | $773.2M | −$26.4M | −3.30% |
| Q2 2010 | 2010-06-30 | $795.8M | −$5.8M | −0.73% |
| Q1 2010 | 2010-03-31 | $739.1M | −$15.4M | −2.04% |
| Q4 2009 | 2009-12-31 | $778.0M | — | — |
| Q3 2009 | 2009-09-30 | $799.6M | $46.1M | +6.12% |
| Q2 2009 | 2009-06-30 | $801.6M | $47.2M | +6.25% |
| Q1 2009 | 2009-03-31 | $754.5M | — | — |
| Q3 2008 | 2008-09-30 | $753.5M | — | — |
| Q2 2008 | 2008-06-30 | $754.4M | — | — |
Quest Diagnostics gross profit trends
Over the last five fiscal years, Quest Diagnostics's gross profit increased from $3.63B to $3.67B, a change of $32.0M. The latest reported quarter, Q2 2026, shows $1.03B.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quest Diagnostics source filings ↗